Oral Oncology
Volume 37, Issue 4 , Pages 369-378 , June 2001

Angiostatin gene therapy inhibits the growth of murine squamous cell carcinoma in vivo

Received 17 July 2000 ,Accepted 31 July 2000.

References 

  1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. New England Journal of Medicine. 1993;328:184–194
  2. Fidler IJ, Ellis LM. The implication of angiogenesis for the biology and therapy of cancer metastases. Cell. 1994;79:185–188
  3. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364
  4. Folkman J. Angiogenesis in cancer, vascular, rhumatoid and other disease. Nature Medicine. 1995;1:27–31
  5. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 1991;66:1095–1104
  6. Ferrara N, Houck L, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial cell growth factor family of proteins. Endocrinology Review. 1992;13:18–32
  7. Dvorak HF, Brown LF, Detmar M, Dvrak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology. 1995;146:1029–1039
  8. Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:6343–6348
  9. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of Thrombospondin-1. Science. 1994;265:1582–1584
  10. Kiura A, Servomaa K, Grenman R, Pulkkinen J, Rytoaa T. p53 mutations in human head and neck cancer cell lines. Acta Otolaryngologica. 1997;529:237–240
  11. Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RC. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. Journal of Pathology. 2000;190:417–422
  12. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma. Cell. 1994;79:315–328
  13. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis Lung Carcinoma. Cell. 1997;88:801–810
  14. Dong Z, Yoneda J, Kumar R, Fidler IJ. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce glanulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine. 1998;188:755–763
  15. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, et al.  Monoclonal antibodies specific for endotherial cells of mouse blood vessels. European Journal of Cell Biology. 1994;63:247–254
  16. Cao Y, O'Reilly MS, Marshall B, Flynn E, Ji R-W, Folkman J. Expression of angiostatin cDNA in murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. Journal of Clinical Investigation. 1998;101:1055–1063
  17. Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C, et al.  Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:6367–6372
  18. Tanaka T, Cao Y, Folkman J, Fine HA. Viral vector-targeted gene therapy utilizing an angiostatin complementary DNA. Cancer Research. 1998;58:3362–3369
  19. Cao Y, Ji R-W, Dabidson D, Schaller J, Marti D, Sohndel S, et al.  Kringle domeins of human angiostatin. Journal of Biological Chemistry. 1996;271:29461–29467
  20. Senger DW, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, et al.  Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer metastasis Review. 1993;12:303–324
  21. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its cobnate receptors in a rat glioma model of tumor angiogenesis. Cancer Research. 1993;53:5822–5827
  22. Krisch M, Strasser J, Allende R, Bello L, Zhang J, Black PM. Angiostatin suppresses malignant glioma growth in vivo. Cancer Research. 1998;58:4654–4659
  23. Fukumura D, Xavier R, Sugiura T, Chen Y, Park E-C, Lu N, et al.  Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715–725
  24. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth facto (VEGF) and its receptors. FASEB Journal. 1999;13:9–22
  25. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Show TB. Identification of a new endothelial growth factor receptor tyrosine kinase. Oncogene. 1991;6:1677–1683
  26. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, et al.  FLT4, a novel class III receptor tyrosine kinase in chromosome5q33-qter. Cancer Research. 1992;52:746–748
  27. Goldfarb M. The fibroblast growth factor family. Cell Growth & Differentiation. 1990;1:439–445
  28. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M. Heldin, C-H. Differential signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry. 1994;269:26988–26995
  29. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, et al.  Increased expression of vascular permeality factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. American Journal of Pathology. 1993;143:1255–1262
  30. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Research. 1993;53:4727–4735
  31. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, et al.  Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Research. 1996;56:172–181
  32. Takahashi T, Talka C, Masuda H, Chen D, Silver M, Kearney M, et al.  Ischemia-and cytokine induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine. 1999;5:434–438
  33. Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, et al.  Endothelial progenitor cells as putative targets for angiostatin. Cancer Research. 1999;59:5875–5877

PII: S1368-8375(00)00100-7

Oral Oncology
Volume 37, Issue 4 , Pages 369-378 , June 2001

Article Tools

* Image Usage & Resolution